European Archives - Page 262 of 1219 - European Medical Journal

Robot-Assisted Surgery: Transforming Bladder Cancer Treatment Outcomes

Evidence from multiple studies and randomised controlled trials suggests that robot-assisted radical cystectomy delivers improved perioperative outcomes.

Stress Echocardiography Predicts Five-Year Cardiovascular Risks

Stress echocardiography predicts five-year cardiovascular risk, guiding treatment for high-risk patients and offering reassurance for low-risk cases.

Unveiling the Gender Divide in Systemic Sclerosis Lung Complications

Men with systemic sclerosis are more prone to ILD, while women face higher risks of SAD, a study reveals critical sex-related differences.

Early Menstruation Tied to Lower Breast Cancer Screening Rates

Despite their higher risk, women with early menarche in Côte d’Ivoire are less likely to undergo breast cancer screenings, a new study finds.

Combination Treatment Shows Promise for Advanced Lung Cancer

A new study has explored the effectiveness of combining transpulmonary chemoembolisation and microwave ablation for treating non-small cell lung cancer…

Gut Microbiome Impacts Tamoxifen Efficacy

A recent study has revealed that the gut microbiota plays a critical role in tamoxifen’s metabolism, influencing its absorption and bioavailability.

15-Year Colonoscopy Interval Safe for Low-Risk Patients

Individuals without a family history of colorectal cancer could safely extend their colonoscopy screenings from the standard 10-year interval to 15 years.

New Insights into Durable Atopic Dermatitis Management

Rocatinlimab, a monoclonal antibody targeting the OX40 receptor on T cells, offers a novel approach to treating atopic dermatitis.

Electrical Nerve Stimulation Improves Long COVID Symptoms

Wearable TENS therapy significantly reduces pain, fatigue, and mobility issues in long COVID, showing promise for symptom management.

Challenges and Advances in Metastatic Bladder Cancer Treatment

Real-world data underline that only a minority of patients complete the recommended 4–6 chemotherapy cycles.